Tacrolimus rescue therapy for severe respiratory failure in the anti-synthetase syndrome

Interstitial lung disease (ILD) is the major determinant of morbidity and mortality in the anti-synthetase syndrome (ASS). The therapeutic efficacy of corticosteroids for the ILD component is limited; hence, additional immunosuppressive and immunomodulatory therapies have been tried with a modicum o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigby, Amy L, Plit, Marshall, Glanville, Allan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184510/
https://www.ncbi.nlm.nih.gov/pubmed/25473571
http://dx.doi.org/10.1002/rcr2.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184510/
https://www.ncbi.nlm.nih.gov/pubmed/25473571
http://dx.doi.org/10.1002/rcr2.52

Ejemplares similares